VOLITIONRX LTD — Director's Dealing 2016

Feb 9, 2016

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2015-12-31

Reporting Person: Micallef Jacob Vincent (Chief Scientific Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	11000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant (Right to Buy)	$2.2	2019-02-26	Common Stock (11000)	11000	Indirect

Footnotes

F1: The reporting person's wife owned the securities reported on Table I and the derivative securities reported on Table II on August 28, 2015, the date on which the reporting person became an officer of the Issuer. These securities were omitted from the reporting person's original Form 3 and were also omitted from the subsequent Form 4.